CLINICAL_TRIALS
trial_result
· 2024-11-08
Clinical Trial Update: A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients [Phase 3]
Summary
Phase 3 trial evaluating the long-term safety and efficacy of ASP1941 in Type 2 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED